Catching up with the catch–up: HPV vaccination coverage data for Australian women aged 18–26 years from the National HPV Vaccination Program Register

Authors

  • Julia Brotherton National HPV Vaccination Program Register, East Melbourne, Victoria
  • Dorota Gertig Victorian Cervical Cytology Registry, Victorian Cytology Service, East Melbourne, Victoria
  • Genevieve Chappell National HPV Vaccination Program Register, East Melbourne, Victoria; Victorian Cervical Cytology Registry, Victorian Cytology Service, East Melbourne, Victoria
  • Lesley Rowlands National HPV Vaccination Program Register, East Melbourne, Victoria; Victorian Cervical Cytology Registry, Victorian Cytology Service, East Melbourne, Victoria
  • Marion Saville Victorian Cervical Cytology Registry, Victorian Cytology Service, East Melbourne, Victoria

DOI:

https://doi.org/10.33321/cdi.2011.35.18

Keywords:

human papillomavirus, immunisation, vaccination coverage

Abstract

This report describes human papillomavirus (HPV) vaccine coverage data for Australian women 18–26 years of age, as notified to the National Human Papillomavirus Vaccination Program Register. A cross-sectional analysis was conducted of notifications to the Register of HPV vaccine doses delivered as part of the National HPV Vaccination Program, which provided free catch-up vaccination to women 18–26 years of age across Australia between 2007 and 2009. HPV vaccination coverage estimates were calculated by age, state or territory of residence and dose number, using the Australian Bureau of Statistics population estimates as the denominator. As at March 2011, approximately 4.49 million doses had been notified to the Register of females of all ages, and 1.7 million of these were for women aged 18–26 years in 2007. Vaccination coverage was highest for females aged 18 years and lowest in females aged 26 years. For the entire 18–26 years cohort, coverage was estimated at 55.2% for dose 1, 44.8% for dose 2 and 31.7% for dose 3. Notified dose 1 coverage rates by single year of age and state or territory ranged between 22% for females aged 26 years in the Northern Territory and 76% in females aged 18 years in Queensland, with dose 1 coverage highest across the age range in the Northern Territory, Queensland and South Australia. These data suggest that over half of Australian women aged 18–26 years commenced HPV vaccine courses and about one-third are fully vaccinated. Some of the differences in the coverage observed between states and territories likely reflect differing mechanisms for notifying to the Register. Commun Dis Intell 2011;35(2):197–201.

Downloads

Download data is not yet available.

References

Lu B, Kumar A, Castellsagué X, Giuliano AR. Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis. BMC Infect Dis 2011;12(11):13.

Brotherton JM. How much cervical cancer in Australia is vaccine preventable? A meta-analysis. Vaccine 2008;26(2):250–256.

Garland SM, Steben M, Sings HL, James M, Lu S, Railkar R, et al. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase iii trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis 2009;199(6):805–814.

Koulova A, Tsui J, Irwin K, Van Damme P, Bielik R, Aquado MT. Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006–January 2008. Vaccine 2008;26(51):6529–6541.

Dorleans F, Giambi C, Dematte L, Cotter S, Stefanoff P, Mereckiene J, et al, on behalf of the VENICE 2 project gatekeepers group. The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey. Euro Surveill 2010;15(47):pii=19730. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19730

National Health and Medical Research Council. The Australian Immunisation Handbook, 9th edn, 2008. Australian Government; Canberra.

Chief Medical Officer. Guidance on revaccination where HPV vaccine doses have been given at less than recommended minimum intervals. Australian Government. Department of Health and Ageing, January 2009. Available from: http://www1.health.gov.au/internet/immunise/publishing.nsf/Content/D5F6C9E0EEAE74FFCA25770300807AA3/$File/CMO-full-advice-hpv.pdf

Brotherton JML, Barbaro B. Why did some practices not notify HPV vaccination: implications for coverage assessment. Proceedings from the Communicable Diseases Control Conference 2011, Hotel Realm, Canberra, Australia, 4–6 April 2011.

Australian Medical Association. Privacy Commissioner advice on HPV Register. GP Network News Issue 09, Number 21, 10 July 2009. Available from: http://ama.com.au/node/4811

Brotherton JML, Mullins R. Will young women have a free HPV vaccine and will it impact on cervical screening? An analysis from Victoria, Australia. Presented at the 26th International Papillomavirus Conference, Montreal, Canada, 3–8 July 2010.

Agius PA, Pitts MK, Smith AM, Mitchell A. Human papillomavirus and cervical cancer: Gardasil vaccination status and knowledge amongst a nationally representative sample of Australian secondary school students. Vaccine 2010;28(27):4416–4422.

Downloads

Published

01/06/11

How to Cite

Brotherton, Julia, Dorota Gertig, Genevieve Chappell, Lesley Rowlands, and Marion Saville. 2011. “Catching up With the catch–up: HPV Vaccination Coverage Data for Australian Women Aged 18–26 Years from the National HPV Vaccination Program Register”. Communicable Diseases Intelligence 35 (June):197-201. https://doi.org/10.33321/cdi.2011.35.18.

Most read articles by the same author(s)

1 2 > >>